Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upfront management of brain metastases in oncogene‑addicted NSCLC - An EORTC survey.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC-ESTRO OligoCare consortium.

The Lancet. Oncology·2026
Same author

First-Line Integration of Local Ablative Therapy With EGFR Tyrosine Kinase Inhibitors in Advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Navigating controversies in stage III NSCLC: a multidisciplinary case discussion on evolving treatment paradigms.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Reply regarding the European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.

The European respiratory journal·2026
Same author

The Optimization of Radiotherapy in Lung Cancer Treatment: 20 Years of Progress.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Related Experiment Video

Updated: Apr 20, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K

Intensity-modulated radiotherapy for lung cancer: current status and future developments.

Clara Chan1, Stephanie Lang, Carl Rowbottom

  • 1*Radiotherapy Related Research, The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom; †Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, United Kingdom; and ‡Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|December 2, 2014
PubMed
Summary

Intensity-modulated radiotherapy (IMRT) improves lung cancer treatment by enhancing dose conformity and sparing normal tissues. This review examines IMRT

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.2K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Related Experiment Videos

Last Updated: Apr 20, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.2K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Clinical Oncology

Background:

  • Radiotherapy is crucial for lung cancer management, with over 50% of patients receiving it.
  • Intensity-modulated radiotherapy (IMRT) offers improved dose conformity and normal tissue sparing compared to conventional techniques.
  • IMRT adoption in lung cancer is increasing, despite limited high-level evidence for routine use.

Purpose of the Study:

  • To review the current evidence for Intensity-modulated radiotherapy (IMRT) in lung cancer treatment.
  • To discuss the challenges associated with implementing IMRT in clinical practice.
  • To provide recommendations for the safe and effective delivery of IMRT for lung cancer.

Main Methods:

  • Systematic review of planning and clinical studies on IMRT for lung cancer.
  • Analysis of data regarding dose distribution, toxicity, and efficacy.
  • Discussion of technical and logistical challenges in IMRT implementation.

Main Results:

  • IMRT demonstrates potential for improved tumor coverage and reduced dose to organs at risk.
  • Planning studies show dosimetric advantages of IMRT.
  • Clinical data on IMRT for lung cancer is still evolving, with ongoing trials.

Conclusions:

  • IMRT is a promising technique for lung cancer radiotherapy, offering dosimetric benefits.
  • Further high-level clinical evidence is needed to support routine IMRT use.
  • Establishing minimum requirements for safe IMRT delivery is essential for widespread adoption.